Correlation Between Innovative Medical and Chengdu Kanghua

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Innovative Medical and Chengdu Kanghua at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Innovative Medical and Chengdu Kanghua into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Innovative Medical Management and Chengdu Kanghua Biological, you can compare the effects of market volatilities on Innovative Medical and Chengdu Kanghua and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Innovative Medical with a short position of Chengdu Kanghua. Check out your portfolio center. Please also check ongoing floating volatility patterns of Innovative Medical and Chengdu Kanghua.

Diversification Opportunities for Innovative Medical and Chengdu Kanghua

0.65
  Correlation Coefficient

Poor diversification

The 3 months correlation between Innovative and Chengdu is 0.65. Overlapping area represents the amount of risk that can be diversified away by holding Innovative Medical Management and Chengdu Kanghua Biological in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Chengdu Kanghua Biol and Innovative Medical is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Innovative Medical Management are associated (or correlated) with Chengdu Kanghua. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Chengdu Kanghua Biol has no effect on the direction of Innovative Medical i.e., Innovative Medical and Chengdu Kanghua go up and down completely randomly.

Pair Corralation between Innovative Medical and Chengdu Kanghua

Assuming the 90 days trading horizon Innovative Medical Management is expected to generate 0.99 times more return on investment than Chengdu Kanghua. However, Innovative Medical Management is 1.01 times less risky than Chengdu Kanghua. It trades about 0.03 of its potential returns per unit of risk. Chengdu Kanghua Biological is currently generating about 0.0 per unit of risk. If you would invest  847.00  in Innovative Medical Management on September 3, 2024 and sell it today you would earn a total of  42.00  from holding Innovative Medical Management or generate 4.96% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthSignificant
Accuracy100.0%
ValuesDaily Returns

Innovative Medical Management  vs.  Chengdu Kanghua Biological

 Performance 
       Timeline  
Innovative Medical 

Risk-Adjusted Performance

13 of 100

 
Weak
 
Strong
Good
Compared to the overall equity markets, risk-adjusted returns on investments in Innovative Medical Management are ranked lower than 13 (%) of all global equities and portfolios over the last 90 days. Despite somewhat weak basic indicators, Innovative Medical sustained solid returns over the last few months and may actually be approaching a breakup point.
Chengdu Kanghua Biol 

Risk-Adjusted Performance

5 of 100

 
Weak
 
Strong
Modest
Compared to the overall equity markets, risk-adjusted returns on investments in Chengdu Kanghua Biological are ranked lower than 5 (%) of all global equities and portfolios over the last 90 days. Despite somewhat weak basic indicators, Chengdu Kanghua sustained solid returns over the last few months and may actually be approaching a breakup point.

Innovative Medical and Chengdu Kanghua Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Innovative Medical and Chengdu Kanghua

The main advantage of trading using opposite Innovative Medical and Chengdu Kanghua positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Innovative Medical position performs unexpectedly, Chengdu Kanghua can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Chengdu Kanghua will offset losses from the drop in Chengdu Kanghua's long position.
The idea behind Innovative Medical Management and Chengdu Kanghua Biological pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Commodity Channel module to use Commodity Channel Index to analyze current equity momentum.

Other Complementary Tools

Price Ceiling Movement
Calculate and plot Price Ceiling Movement for different equity instruments
Sectors
List of equity sectors categorizing publicly traded companies based on their primary business activities
Efficient Frontier
Plot and analyze your portfolio and positions against risk-return landscape of the market.
Sign In To Macroaxis
Sign in to explore Macroaxis' wealth optimization platform and fintech modules
Volatility Analysis
Get historical volatility and risk analysis based on latest market data